NovaBay Pharmaceuticals Inc (AMEX:NBY)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - NBY

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - NBY

  • Market Cap$16.490m
  • SymbolAMEX:NBY
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS66987P2011

Company Profile

NovaBay Pharmaceuticals Inc is a biopharmaceutical company. The company develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eyecare market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). NovaBay develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing and developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX and CELLERX.

Latest NBY news

Currently there for this company. Visit our news hub for other news .